Procter Gamble Health Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5261 as of 18 May 15:30 . The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The p/e ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 to 0 over 9 quarters. This represents a CAGR of 0.0% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The market cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The revenue of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -100% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 4.04 crore as compare to the Dec '25 revenue of ₹ 1.62 crore. This represent the growth of 149.38% The ebitda of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the decline of -100% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.11 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the growth of 175% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ -0.5 crore to ₹ 0.11 crore over 8 quarters. This represents a CAGR of NaN% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Procter & Gamble Health Ltd is 8,775 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 29 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 18, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5286.55. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹25.3.

How do dividend payouts of Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.